#AANAM – Rituximab Effective in Real World in Adults With Refractory gMG

#AANAM – Rituximab Effective in Real World in Adults With Refractory gMG

292310

#AANAM – Rituximab Effective in Real World in Adults With Refractory gMG

Editor’s note: The Myasthenia Gravis News Today team is providing in-depth coverage of the 2021 Virtual AAN Annual Meeting, April 17–22. Go here to read the latest stories from the conference Rituximab, an approved immunosuppressive treatment for certain cancers and autoimmune conditions, effectively eases disease severity and prevents relapses in adults with generalized myasthenia gravis (gMG) who fail to respond to available therapies, according to a small, real-world study in Argentina. Notably, neither high doses of…

You must be logged in to read/download the full post.